Business Standard

Bharat Biotech's Covaxin gets expert panel's nod for children above 2 years

First Covid-19 vaccine in the world for children this young

covaxin, bharat biotech, coronavirus vaccine, covid-19, vaccination
Premium

Bharat Biotech has struggled to keep pace with demand for its Covid-19 shots

Sohini Das Mumbai
Bharat Biotech’s Covaxin will become the world’s first Covid-19 vaccine approved for use in children as young as 2 years. The expert panel advising India’s drug regulator on Tuesday recommended granting emergency use authorisation to the vaccine for children in the 2-18 years age group.  

The Hyderabad-based company has been asked to submit data on any adverse event following vaccination every 15 days for the next two months. It has also been told to update the package inserts, fact sheet, and summary of product characteristics for its vaccine pack.

Bharat Biotech said it was awaiting further regulatory approval from the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in